Agios Pharmaceuticals | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
AbbVie USD 9.34B 1.36B 2025-03
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amgen USD 5.54B 430M 2025-03
Arrowhead Research -173085000 2.55M 2024-12
Astellas Pharma JPY 410.96B 28.53B 2025-06
AstraZeneca USD 11.35B 819M 2025-03
Bayer EUR 8.11B 2.11B 2025-03
Biogen USD 1.8B 69.5M 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Daiichi Sankyo JPY 424.35B 67.89B 2025-03
Eli Lilly USD 10.5B 624.7M 2025-03
Exelixis USD 548.79M 12.52M 2025-06
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Incyte USD 1.14B 151.67M 2025-06
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
Merck USD 12.99B 224M 2025-06
Moderna USD 17M 403M 2025-03
Novartis USD 11.51B 1.12B 2025-06
Novartis USD 10.24B 313M 2024-12
Pfizer USD 11.12B 987M 2025-03
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12


Agios Pharmaceuticals Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.